Daniel J. Griffin
Research Subjects
Daniel J. Griffin has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
- Hsiao-Wu Hsieh
Drug Substance Technologies - Synthetics, Process Development, Amgen Inc., 360 Binney St. Cambridge, Massachusetts 02142, United States
5 shared publications - Matthew G. Beaver
Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States
5 shared publications - Andrew T. Parsons
Process Development, Amgen, Inc., Cambridge, Massachusetts 02142, United States
4 shared publications - Oliver R. Thiel
Chemical Process Research & Development, Amgen, Inc. One Amgen Center Drive, Thousand Oaks, CA 91320-1799 (USA)
4 shared publications Alicia Zeng
Pivotal Attribute Sciences, Amgen, Inc., Cambridge, Massachusetts 02142, United States
3 shared publications- Derek B. Brown
Pivotal and Commercial Synthetics, Drug Substance Technologies, Process Development, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States
3 shared publications
Latest Publications
- 27 July 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
Versatile Construction of a 4-Substituted Piperidine by Continuous Preparation of a Complex Grignard and Addition to an In Situ Generated Pyridinium Species
A robust and enabling synthesis of a sterically encumbered 4-substituted piperidine, a common motif in a novel KRAS G12C inhibitor series, was developed. It was discovered that the critical congested C–C bond could be forged by the regioselective addition of a functionalized Grignard reagent to an N-carbamyl pyridinium species. Kinetic studies demonstrated that the Grignard species was inherently unstable, leading to diminished yields in large-scale batch processes. A semicontinuous reactor train was developed to generate the Grignard continuously using a plug flow reactor, which flowed directly into a stirred reactor containing the preformed pyridinium species. This system was utilized to produce >100 g quantities of the Grignard adduct in a single operation, which could be converted to the desired 4-substituted piperidine in two additional steps. Further studies determined that regioselectivity was governed by the steric environment of the nucleophilic Grignard species.
- 27 July 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
Versatile Construction of a 4-Substituted Piperidine by Continuous Preparation of a Complex Grignard and Addition to an In Situ Generated Pyridinium Species
A robust and enabling synthesis of a sterically encumbered 4-substituted piperidine, a common motif in a novel KRAS G12C inhibitor series, was developed. It was discovered that the critical congested C–C bond could be forged by the regioselective addition of a functionalized Grignard reagent to an N-carbamyl pyridinium species. Kinetic studies demonstrated that the Grignard species was inherently unstable, leading to diminished yields in large-scale batch processes. A semicontinuous reactor train was developed to generate the Grignard continuously using a plug flow reactor, which flowed directly into a stirred reactor containing the preformed pyridinium species. This system was utilized to produce >100 g quantities of the Grignard adduct in a single operation, which could be converted to the desired 4-substituted piperidine in two additional steps. Further studies determined that regioselectivity was governed by the steric environment of the nucleophilic Grignard species.
- 25 June 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (7) , 1746-1780
Automation in Pharmaceutical Crystallization
- 25 June 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (7) , 1746-1780
Automation in Pharmaceutical Crystallization
- Open Access
- 18 May 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (6) , 1452-1464
Robust ATR-FTIR Calibration for Concentration Monitoring in Mixed-Solvent Crystallization Processes
- 18 May 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (6) , 1452-1464
Open AccessRobust ATR-FTIR Calibration for Concentration Monitoring in Mixed-Solvent Crystallization Processes
- 2 June 2025
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (6) , 1456-1464
Development of an Improved Process To Prepare a Key Intermediate in the Manufacture of Sotorasib
- 2 June 2025
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (6) , 1456-1464
Development of an Improved Process To Prepare a Key Intermediate in the Manufacture of Sotorasib
- 25 June 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (7) , 2844-2853
PAT-Enabled Automated Feedforward Control: An Application to the Continuous Manufacture of Apremilast
- 25 June 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (7) , 2844-2853
PAT-Enabled Automated Feedforward Control: An Application to the Continuous Manufacture of Apremilast
- 13 February 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (5) , 1385-1401
A Continuous Process for Manufacturing Apremilast. Part II: Process Characterization to Establish a Parametric Control Strategy
- 13 February 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (5) , 1385-1401
A Continuous Process for Manufacturing Apremilast. Part II: Process Characterization to Establish a Parametric Control Strategy
- 2 February 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (5) , 1369-1384
A Continuous Process for Manufacturing Apremilast. Part I: Process Development and Intensification by Utilizing Flow Chemistry Principles
- 2 February 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (5) , 1369-1384
A Continuous Process for Manufacturing Apremilast. Part I: Process Development and Intensification by Utilizing Flow Chemistry Principles
- Open Access
- 25 September 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (11) , 1868-1879
Opportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development
- 25 September 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (11) , 1868-1879
Open AccessOpportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development
- 31 July 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (8) , 1499-1509
Developing and Optimizing a Quench-Crystallization Operation in Drug Substance Manufacturing
- 31 July 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (8) , 1499-1509
Developing and Optimizing a Quench-Crystallization Operation in Drug Substance Manufacturing
- 19 October 2022
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (11) , 3115-3125
Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor
- 19 October 2022
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (11) , 3115-3125
Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor